07:14 28-11-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion

Bishkek (AKIpress) - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Twitterfacebookprint
16:29 20.06.2014
LATEST NEWS
17:49 Switzerland represents Latvia in visa matters in Kyrgyzstan17:43 UNHCR, State Registration Service update action plan on prevention and reduction of statelessness17:39 Kyrgyzstan presents online performances of manaschy, Kyrgyz folk music to Czech Republic and Malaysia17:31 Kyrgyzstan needs to attract $7 billion of investments annually – Economy Minister17:22 Kyrgyzstan lacks accurate data on total number of cattle – MP17:14 Health Ministry working to prevent introduction, spread of Ebola virus in Kyrgyzstan – Government17:02 Polish entrepreneurs reportedly set to build car factory in Kochkor district17:00 Oil price at four-year low as Opec meets16:56 Uzbekistan proposes Russia to export vegetables directly without Kazakhstan's intervention – Deputy PM16:55 U.S. Ambassador to hold public lecture on cooperation with OSCE on Central Asia's security issues16:49 Bishkek City Council approves allotment of 3 mln som for development of hostel for persons of no fixed abode16:40 Czech President completes his official visit to Tajikistan16:39 Vice PM of Kyrgyzstan, Federal Government Commissioner of Germany discuss cultural and humanitarian cooperation16:29 Kazakh delegation participates in General Assembly of International Exhibitions Bureau16:13 3,405 documents for permanent residence processed in January-September 201416:02 National Institute for Strategic Studies, Institute of Central Asia Studies at Shaanxi Normal University sign memo of cooperation15:50 Ombudsman: 60% of appeals, complaints fall at law enforcement, judicial agencies15:44 $13 million tax debt of Tajikistani railway company written off - decree15:40 Education Ministry introduces AVN system to improve efficiency of public services in education sector15:23 Tajikistan blocks drug supply chain from Afghanistan to CIS countries
Astana
-19° C
Ashgabat
+6° C
Bishkek
-6° C
Dushanbe
+9° C
Tashkent
+1° C
exchange rates
 
71.82
57.58
9.40
1.24
225.49
180.87
29.47
3.88
6.34
5.09
0.83
0.11
3042.15
2388.25
390.42
56.91
3.55
2.85
0.46
0.06

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75